Introduction: The number of people with Type 2 DM is increasing in every country with 80% of people with diabetes mellitus (DM) living in low and middle income countries The treatment options for Type 2 DM has increased over the years with the availability of the various classes of antidiabetic medications. The current objective of the study is to screen the prescription trends in Type 2 DM, assessing glycaemic control and studying demographic and anthropometric parameters in a rural setting. Material and Methods– This observational study was conducted prospectively in department of Medicine DRPGMCH Tanda at Kangra. One hundred ninety patients of Type2 DM over a period of two months (July and august,2019) coming to medicine OPD were enrolled. Results: Male to female ratio was 1.1:1. Minimum age of the patient was 30 yrs and maximum 88 yrs. BMI had no impact on glycemic control in our study. Out of 190 patients, it was found that 56(29.5%) were on monotherapy and 136 (71.5%) patients were on combination therapy. Biguanides were the most commonly prescribed drug as monotherapy (22.8%) and in combination (88.4%). Sulphonylureas (SU) was the second preferred drug. In our study the third most common OHA was DPP4 I as monotherapy or in combination( 32.6%). 62.6% patients on antidiabetic drugs had adequate glycaemic control while 37.4% patients had inadequate glycaemic control. Conclusion: OHA still dominate the prescription pattern and biguanides are the most commonly prescribed drugs, but newer drugs like DPP4I have found a significant place in prescription pattern.